| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Svoronos Dawn is a Director at PTC THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2023 | XENE Xenon Pharmaceuticals Inc. | Director | Sell | 25,000 | $38.70 | $967,500.00 | -50.0% | -25.0% | +6.4% | |
| Jun 9, 2022 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 738 | $27.20 | $20,074.34 | -2.5% | +93.1% | +54.4% | |
| Jan 7, 2022 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 510 | $38.53 | $19,647.75 | -1.9% | +12.9% | +3.2% | |
| Jun 9, 2021 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 365 | $41.89 | $15,288.03 | -1.3% | +3.9% | -33.4% | |
| Feb 1, 2021 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 506 | $56.96 | $28,819.74 | -1.8% | - | - | |
| Jun 11, 2020 | PTCT Ptc Therapeutics, Inc. | Director | Sell | 364 | $48.36 | $17,603.04 | -1.4% | - | - | |
| Aug 14, 2017 | XENE Xenon Pharmaceuticals Inc. | Director | Buy | 50,000 | $2.82 | $140,770.00 | New | - | - | |
| May 23, 2017 | PTCT Ptc Therapeutics, Inc. | Director | Buy | 25,000 | $13.49 | $337,230.00 | New | - | - |